Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 26 announcements

Share price: ₹385.20
Market cap: ₹660.6 Cr
Revenue (annual): ₹46.57 Cr
Net profit (annual): ₹4.62 Cr
P/E (TTM): 143.0×Sector 47.4×
Promoter holding: 72.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

28 Apr 2026 20:06 IST BSE

Aptus Pharma Results Update

Aptus Pharma Limited reported robust FY26 financial results, with total revenue doubling to ₹46.71 Crore and PAT increasing by 49% to ₹4.62 Crore. The company expanded its portfolio to over 250 formulations and services 25K+ retail outlets. Aptus aims for a pan-India presence by 2030 through its asset-light manufacturing model and strategic vertical expansion.

Read the filing ↗